Healthcare stocks declined Tuesday afternoon, with the NYSE Healthcare Index shedding 0.6% and the State Street Health Care Select Sector SPDR ETF (XLV) decreasing 0.4%.
The iShares Biotechnology ETF (IBB) rose 0.3%
In corporate news, Hims & Hers Health (HIMS) shares were down 3.8% following its Q2 results. The results were mixed, with upside in its US business from branded GLP-1 strength and a ramp in testosterone offset by disappointing gross margin and weak free cash flow, Morgan Stanley said in a note.